PRG Science & Technology Co., Ltd.
5 clinical trials · Sponsor
◉ Watch PRG Science & Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II (NCT07131722) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome (NCT05847179) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis (NCT07221240) | PRG Science & Technology Co., Ltd. | 2025-10-01 |
| Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) (NCT06775041) | PRG Science & Technology Co., Ltd. | 2025-01-13 |
| Phase I Study of Progerinin in Healthy Volunteers (NCT04512963) | PRG Science & Technology Co., Ltd. | 2020-08-24 |
Track PRG Science & Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.